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INTRODUCTION
The addition of a methyl group to CpG dinucleotides is an
essential contribution to an epigenetic mechanism by which
the mammalian genome is programmed to establish differ-
ent sets of genes expressed in different tissues (1, 2). The main-
tenance DNA methyltransferase has a replication error rate
of up to 5% during somatic cell division (1). In contrast to
the identical DNA sequence that is found in every cell, vari-
ation in DNA methylation can result in a tissue-specific pat-
tern and is necessary to meet the demands of the later-life envi-
ronment. Individuals that become infected with Helicobacter
pylori undergo a series of discrete gastric mucosal changes dur-
ing their lifetime (3). In a mouse model infected with H. pylori,
long-standing gastric mucosal damage and the resultant mu-
cosal changes are known to precede the development of gas-
tric cancer (4). Therefore, in non-cancer individuals, repeat-
ed mucosal injuries are likely to induce adaptive methylation
changes that enable efficient wound healing and act as a mea-
sure against cancer evolution.
The methylation-variable sites that locate in promoter or
noncoding neutral regions have demonstrated gradual methy-
lation changes associated with the aging or long-term adap-
tation process (5). A previous study proposed the presence of
transitional-CpG sites between the unmethylated promoters
and nearby densely methylated retroelements in order to des-
cribe the complexity of variable methylation in gene control
regions (6, 7). The transitional-CpG sites at the margin of
the CpG islands and at the non-island CpG sites around the
transcription start sites have been found to be either under-
or over-methylated in a tissue-specific manner as well as to
be methylated to various degrees in the same tissue type (7).
This suggests that the methylation-variable sites nearest to
the transcription start sites may serve as epigenetic markers
for adaptive DNA methylation.
There is a large body of evidence indicating that gene expres-
sion depends on communication between DNA methylation
and histone modification that induces chromatin condensa-
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DNA Methylation Patterns of Ulcer-Healing Genes Associated with the
Normal Gastric Mucosa of Gastric Cancers
Recent evidence suggests that gastric mucosal injury induces adaptive changes
in DNA methylation. In this study, the methylation status of the key tissue-specific
genes in normal gastric mucosa of healthy individuals and cancer patients was eval-
uated. The methylation-variable sites of 14 genes, including ulcer-healing genes
(TFF1, TFF2, CDH1, and PPARG), were chosen from the CpG-island margins or
non-island CpGs near the transcription start sites. The healthy individuals as well
as the normal gastric mucosa of 23 ulcer, 21 non-invasive cancer, and 53 cancer
patients were examined by semiquantitative methylation-specific polymerase chain
reaction (PCR) analysis. The ulcer-healing genes were concurrently methylated with
other genes depending on the presence or absence of CpG-islands in the normal
mucosa of healthy individuals. Both the TFF2 and PPARG genes were frequently
undermethylated in ulcer patients. The over- or intermediate-methylated TFF2 and
undermethylated PPARG genes was more common in stage-1 cancer patients (71%)
than in healthy individuals (10%; odds ratio [OR], 21.9) and non-invasive cancer
patients (21%; OR, 8.9). The TFF2-PPARG methylation pattern of cancer patients
was stronger in the older-age group (≥55 yr; OR, 43.6). These results suggest that
the combined methylation pattern of ulcer-healing genes serves as a sensitive mark-
er for predicting cancer-prone gastric mucosa.
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tion (1). In addition, the dynamic chromatin structure is known
to assemble transcription machinery on a master gene that
enables the well-coordinated expression of tissue-specific genes
and housekeeping genes (also known as the self-organization
model) (8). In this regard, the methylation-variable site of a
strongly expressed tissue-specific gene can influence the expres-
sion of the nearby gene as well as its related genes. Therefore,
the methylation-variable sites of the key gastric-specific genes
are expected to participate in the discrete mucosal adaptation
and encapsulate the interactive methylation patterns that lead
to mucosal changes, including gastric cancers.
In this study, the methylation profiles of 14 genes includ-
ing the ulcer-healing genes, TFF1,TFF2,CDH1, and PPARG
(9-11), in the normal gastric mucosa were delineated by exam-
ining the nearby methylation-variable sites. Both the TFF2
and PPARG genes were frequently undermethylated in the
normal mucosa of ulcer patients. However, although the PP-
ARG gene was undermethylated in the normal mucosa of
cancer patients, the TFF2 gene was barely undermethylated,
even when it was in close proximity to the cancer margin. In
addition, a combination of over- or intermediate-methylated
TFF2 and undermethylated PPARG genes was more com-
mon in stage-1 cancer patients than in healthy individuals
(odds ratio [OR], 21.9) and non-invasive cancerous patients
(OR, 8.9). These results suggest that the methylation-vari-
able sites of the ulcer-healing genes may be accurate epige-
netic markers for a high risk of gastric cancer.
MATERIALS AND METHODS
Normal gastric mucosa and pathologic tissues 
Seventy healthy individuals, 53 gastric cancer patients, 21
gastric non-invasive cancer patients, and 23 invasive gastric
ulcer patients between September 2005 and July 2007 were
enrolled in this study (Table 1). The control and patient groups
all underwent either an endoscopic biopsy or a surgical resec-
tion at St. Paul’s Hospital and St. Vincent’s Hospital, The
Catholic University of Korea. All subjects provided informed
consent and the study was approved by the institutional review
board (Document number 48, ‘Genetic study of gastrointesti-
nal cancer’, January 28, 2005, St. Paul’s Hospital, The Catholic
University of Korea, Seoul, Korea). For the normal controls,
two biopsy-tissue specimens were obtained from the antrum
and the body of the normal stomach separated by a distance
of 5 cm. The normal gastric mucosa of gastric ulcer, non-inva-
sive cancer, and invasive cancer patients were endoscopically
obtained 2 and 5 cm away from the lesion margin. Resected
non-invasive and invasive cancer tissues were microscopical-
ly dissected in order to purify the normal epithelial cells within
1 cm of the lesion margin as well as the non-invasive and inva-
sive cancerous cells.
To diagnose Helicobacter pylori infection, the paired biopsy
samples collected 2-cm from the normal mucosal sites select-
ed for methylation analysis were stained using the Warthin-
Starry silver impregnation method. The grade of gastric atro-
phy was evaluated using the endoscopic atrophic border scale
described by Kimura and Takemoto (12), which correlates
with the results of the histological evaluations. Gastric non-
invasive cancer and invasive cancer was diagnosed according
to the Vienna classification of gastrointestinal epithelial neo-
plasia (13). Gastric ulcers that appeared malignant were de-
fined based on an endoscopists impression of ulceration in the
stomach and a microscopic examination showing no invasive
cancer cells. The clinicopathological tumor stage was deter-
mined using the Tumor-Node-Metastasis (TNM) criteria (14). 
Histological analysis of the normal mucosa confirmed that
the biopsy tissues consisted primarily of normal gastric epithe-
lial cells and showed no evidence of cancer cell invasion or sig-
nificant inflammation. All of the microdissected cancer tissues
contained a cancer cell content of ≥80%. Approximately 50
cells were digested in 1 mL of a Tween 20-Proteinase K lysis
buffer after which a DNA isolation kit (A1120, Promega,
Madison, WI, USA) was used to extract the genomic DNA
according to the manufacturer’s instructions. 
Percentages are indicated in parentheses. 
*The grade of gastric atrophy was determined endoscopically. The C-
type atrophy is localized in the antrum and the lesser curvature of the
lower and upper body. The O-type atrophy spreads to the anterior wall
and greater curvature of the body. The gastric atrophy is mild in order
of C1, C2, C3, O1, O2, and O3. 
Normal Ulcer
Non-invasive
cancer
Invasive 
cancer
No. of cases 70 23 21 53
Sex
Male 38 (54) 17 (74) 13 (62) 37 (70)
Female 32 (46) 6 (26) 8 (38) 16 (30)
Age (yr)
<55 28 (40) 8 (35) 3 (14) 11 (21)
≥55 42 (60) 15 (65) 18 (86) 42 (79)
Helicobacter pylori
Yes 33 (47) 11 (48) 14 (67) 22 (42)
No 37 (53) 12 (52) 7 (33) 31 (58)
Histologic features
Atrophy* Histologic grade Tumor stage
Absence 32 (46) Low   14 (66) 1   24 (45)
C1     3 (4) High   7 (34) 2   10 (19)
C2   17 (25) 3   12 (23)
C3   10 (14) 4     7 (13)
O1     5 (7) Tumor size
O2     1 (1) in diameter
O3     2 (3) <4 cm   27 (51)
≥4 cm   26 (49)
Table 1. Descriptive characteristics of normal controls and gas-
tric ulcer, non-invasive and invasive cancer patientsDNA Methylation in Normal Mucosa of Gastric Cancer 407
Semiquantitative methylation analysis 
A search of the genes expressed in normal gastric mucosa
and gastric cancers was made from eight SAGE (Serial Analy-
sis of Gene Expression) libraries of four normal gastric mucosa
and four gastric cancers that were obtained from a public data-
base (http://cgap.nci.nih.gov/SAGE/). Highly expressed gas-
tric genes (PGA5 and PGC) (15), ulcer-healing genes (TFF1,
TFF2, CDH1, and PPARG) (9-11), cancer-associated genes
(MLH1, CDKN2A, and RUNX3) (16, 17), weakly active
genes (MSLN, ARRDC4, and DUPS6) (18-20), and non-gas-
tric genes (KRT6A and TRAPPC2L) (21, 22) were selected
to evaluate the methylation-variable sites. Based on a review
of studies conducted to evaluate the transcription of each gene,
the transcript number of individual genes counted in the SAGE
data was found to accurately estimate a wide range of strong
and weak transcription. The primer sites, sequences, and con-
ditions are shown in Fig. 1, Table 2.
Each CpG amplicon site was analyzed by cloning and sequ-
encing the common-polymerase chain reaction (PCR) prod-
ucts encompassing both the unmethylated and methylated
CpGs, as previously reported (7, 16, 23, 24). Standard curves
were then plotted for each methylation specific PCR (MSP)
primer set using a mixture containing the methylated and
unmethylated DNA clones at various ratios. The methylation
status of the methylation-variable sites was scored at the fol-
lowing 5 levels by calculating the relative proportion of the
methylation amplicon to the total intensity of unmethylation
and methylation amplicons (7, 16, 23-25): 1 (0-20% methy-
lation), 2 (21-40% methylation), 3 (41-60% methylation),
4 (61-80% methylation), and 5 (81-100% methylation) (Fig.
2). Because the number and position of methylated CpG din-
ucleotides were so heterogeneous in the methylation-variable
sites, a wide range of methylation-variations was categorized
as either under- and over-methylation based on an intermedi-
ate methylation level that was dominant in normal stomach
samples (Fig. 3A).
The methylation-variable sites containing a low GC con-
tent and simple repeat sequence provided very limited sequ-
ences for the design of MSP primers. Therefore, a stringent
PCR condition using a low concentration of dNTP was nec-
essary to enable the specific amplification of simple sequences.
The use of a dTTP-radioisotope was an essential step in gen-
erating the sharp electrophoresis bands required for semiquan-
titative MSP analysis. The reproducibility of semiquantita-
tive MSP analysis was ensured using the following protocols:
1) 10 mL of a PCR mixture contained 1 mCi of a-
32P dTTP
(PerkinElmer, Boston, MA, USA), 62.5 mM dATP, dCTP, and
dGTP, 25 mM dTTP, 1 pM of primers, 0.1% Tween 20 and
0.3 unit of Taq polymerase, 2) a fresh genomic DNA of 10
PGA5
PGC
TFF1
TFF2
MSLN
KRT6A
ARRDC4
CDH1
DUSP6
MLH1
PPARG
TRAPPC2L
CDKN2A
RUNX3
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transcription start site TSS,
Fig. 1. Schematic diagram of the length of the CpG-islands and the retroelement distributions in the 5′ -end regions of 14 selected genes
(A) and their serial analysis of gene expression (SAGE) profiles in the normal gastric mucosa and gastric cancer tissue (B). 
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to 20 ng/mL was used for bisulfite modification, 3) each primer
set covering 3-5 CpG sites was designed to generate a small
amplicon of ≤150 bp, 4) bisulfite-modified DNA was ampli-
fied by subjecting it to 32 PCR cycles under hot-start PCR
conditions, and 5) each MSP primer set was found to repro-
duce the same range of band intensity in more than 95% of
duplicated experiments using the same biopsy tissue DNA
(7, 16, 23, 24).
Comparison of radioisotope-labeling and non-radioisotope
methods
Fourteen methylation-variable sites per each bisulfite-mod-
ified template DNA were amplified concurrently using the
same PCR mixture and machine (Fig. 2). A total of 28 MSP
amplicons was electrophoresed simultaneously on polyacry-
lamide gels. The dTTP-labeling protocol resulted in the bal-
anced amplification of the unmethylated and methylated low-
CpG DNA and allowed the semiquantitative measurement
of methylation levels. However, when the non-radioisotope
PCR protocol was used on the same samples subjected to the
same PCR conditions, weak signals, noisy backgrounds, and
smearing bands were often observed. The real-time PCR pro-
tocols, which have been used to measure methylation-depen-
dent amplification of the CpG-rich island sites, also showed
unstable and weak amplicon intensities in the methylation-
variable sites (26). 
Statistical analysis
A Fisher’s exact test was used to determine if there were
any significant differences in the frequency of under- or over-
methylation in the mucosa of normal stomach versus either
normal gastric mucosa or pathologic tissues obtained from
ulcer, non-invasive cancer and cancer patients. The levels of
methylation estimated in the mucosa of normal stomach and
pathologic lesions were compared using a Mann-Whitney
U test. The correlation coefficient was calculated to determine
the concurrent methylation pattern between the ulcer-heal-
ing (CDH1,TFF1, and TFF2) genes and the other genes. The
odds ratios and 95% confidence intervals (CI) were calculat-
ed using the relevant 2×2 contingency tables. Two-sided P
values of <0.01 were considered to be significant.
CpG sites are indicated by the name of the gene and the distance from the transcription start site.
PCR, polymerase chain reaction; U, unmethylation; M, methylation.
Genomic position Size
(bp)
Tm
(°C)
Sequence of forward primer Sequence of reverse primer Gene 
symbol
PGA5 0 kb U GATTTTTAGAGGTTGATAAGGT TTCTTCCCAAATCCCAACTCA 115 55
M GATTTTTAGAGGTCGATAAGGC TTCTTCCCGAATCCCAACTCG 115 55
PGC  Upstream 0.2  kb U GGTGTATTTTGTGTTTTGTGTATT ACTTACACCTCCTAACCTCCA 117 60
M GTGTATTTTGTGTTTCGTGTATC GCTTACACCTCCTAACCTCCG 118 60
TFF1 Downstream 0.1 kb U TGGGTTTTGGTTAGGGTGTT CTCATCCCTAACTCAAAATCA 123 53
M TGGGTTTCGGTTAGGGTGTC CTCATCCCTAACTCGAAATCG 123 53
TFF2  Upstream 0.2  kb U GGTAGTTGTGTTTTGTGTAGGT CACATAACCAATTTTCCACA 130 56
M GGTAGTTGTGTTTTGTGTAGGC CACGTAACCGATTTTCCACG 130 62
MSLN  Upstream 0.8  kb U GGAGAGATTAGAGATGATTGTTGT CATAAACTCTTATCCCCAATACA 103 55
M GGAGAGATTAGAGATGATCGTCGC CGTAAACTCTTATCCCCAATACG 103 60
KRT6A Downstream 0.1 kb U TTTTGGAGTGGGATATGGAGAT AAAACCACAACAACAACCACCA 104 60
M TTTTGGAGCGGGATACGGAGAC AAAACCACAACAACAACCGCCG 104 60
ARRDC4  Upstream 0.3  kb U GAATGGTTGATATGTTGAGAGTT CCCTAACCAATAATAAAACAATACA 112 55
M GAACGGTTGATACGTTGAGAGTC CCCTAACCAATAATAAAACGATACG 112 53
CDH1  0 kb U GGTGAATTTTTAGTTAATTAGTGGTAT TCACAAATACTTTACAATTCCAACA 108 56
M TGAATTTTTAGTTAATTAGCGGTAC ACAAATACTTTACAATTCCGACG 104 58
DUSP6 Upstream 2.1  kb U GTTTTAGTTGGGGGAGGTTTGT TCCCAATAACTAAAACATCTCA 100 56
M GTTTTAGTCGGGGGAGGTTTGC TCCCAATAACTAAAACGTCTCG 100 56
MLH1  Upstream 1.0  kb U GATTTTAGGATTGTTGATATGAGT AAACTACCTCCTAATCTTTATCCA 126 58
M GATTTTAGGATTGTCGATATGAGC AACTACCTCCTAATCTTTATCCG 125 58
PPARG  Upstream 1.5  kb U AGAAGAGAAAATTAAGGGATTT ATAACTTACCCTTCACACAACA 117 58
M AGAAGAGAAAATTAAGGGATTC ATAACTTACCCTTCACACGACG 117 58
TRAPPC2L  Upstream 0.7  kb U GGGAGTGATTTTTAGGGTGAT TCCCCCATCTAACCTTTCCCA 129 53
M GGGAGTGATTTTTAGGGCGAC TCCCCCGTCTAACCTTTCCCG 129 53
CDKN2A  Upstream 1.6  kb U TTGGGATTAGGTTTAGTTTTGG CTATAAAACCCTATCAACTCACACT 130 58
MT C GGGATTAGGTTTAGTTTCG AAACCCTATCGACTCACGCT 125 60
RUNX3  Upstream 1.7  kb U TGGGGTTAGATTTTTGTTGTTTTT ATAAAATCTTACAACCACCATCA 107 56
MC GGGGTTAGATTTTCGTTGTTTTC ATAAAATCTTACGACCACCGTCG 107 58
Table 2. List of methylation specific PCR primer setsDNA Methylation in Normal Mucosa of Gastric Cancer 409
RESULTS
Methylation-variations in the mucosa of normal stomach
The methylation status of the methylation-variable sites
of 14 genes in the antrum and body of 70 normal stomachs
was evaluated (Fig. 3A). Intermediate-level methylation was
dominant for most of the genes examined in the normal stom-
ach samples. Because the TFF1,TFF2, and CDH1 genes were
methylated to various degrees in an age-dependent manner
(Fig. 4A), the intermediate-level methylation of these three
genes was relatively less frequent. When the normal stom-
ach samples were divided into four age groups (≤44 yr [n=
22], 45 to 54 yr [n=34], 55 to 64 yr [n=42], and ≥65 yr [n=
42]), the TFF1 gene was more overmethylated in the older-
aged group (≥55 yr) than in the younger-aged group (49%
vs. 21%, respectively, P=0.002). The TFF2 gene was more
undermethylated in the older-aged group (≥65 yr) than in
the younger-aged groups (55% vs. 27%, respectively, P=
0.002). The overmethylation of the CDH1 gene was most
frequent in the age group that ranged from 45 to 54 yr (56%
vs. 25%, respectively, P=0.012) and was associated with H.
pylori infection (P<0.001, Fig. 4B). 
Variations in methylation detected in normal stomach sam-
ples were analyzed to identify any possible relationships with
the anatomic site, gender, age, and gastric atrophy (data not
shown). The undermethylation of the TRAPPC2L non-gas-
tric gene was more common in the body than in the antrum
(36% vs. 4%, respectively, P<0.001) and more common in the
older-aged group (≥55 yr) than in the younger-aged group
(<55 yr) (29% vs. 4%, respectively, P=0.001). 
Methylation-variations in the normal mucosa of ulcer, non-
invasive cancer, and invasive cancer patients
The methylation status of the 14 selected genes was ana-
lyzed in normal mucosal tissues located 2 cm and 5 cm dis-
tal from 23 ulcerative, 21 non-invasive cancerous and 53 inva-
sive cancerous lesions (Table 3). The methylation status of each
gene was then compared between the paired normal mucosa
(2 and 5 cm distances) of the pathologic lesions and the paired
mucosa (antrum and body) of normal stomach samples. In
Fig. 2. Representative autoradio-
graphs and ethidium bromide
staining of electrophoresis bands
generated from both unmethyla-
tion (U) and methylation (M) PCR.
Genomic DNA was obtained from
normal mucosa of normal control
(A), gastric ulcer (B), non-invasive
cancer (C), and stage-1 cancer (D)
patients. 
A
Level 3 Level 3 Level 3 Level 2 Level 4 Level 4 Level 1 Level 3 Level 3 Level 2 Level 2 Level 3 Level 2 Level 3
UM UM U M UM UM U M UM UM UM UM UM UM UM UM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
UMUMUMUMUMUM UMUMUMUMUM U MUMUM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
B
Level 2 Level 2 Level 1 Level 2 Level 5 Level 4 Level 1 Level 1 Level 1 Level 2 Level 1 Level 2 Level 2 Level 2
UM UM U M UM UM U M UM UM UM UM UM UM UM UM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
UMUMUMUMUMUM UMUMUMUMUM U MUMUM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
C
Level 3 Level 4 Level 3 Level 3 Level 4 Level 4 Level 2 Level 3 Level 2 Level 2 Level 2 Level 2 Level 3 Level 4
UM UM U M UM UM U M UM UM UM UM UM UM UM UM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
UMUMUMUMUMUM UMUMUMUMUM U MUMUM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
D
Level 3 Level 3 Level 2 Level 3 Level 4 Level 4 Level 1 Level 2 Level 2 Level 2 Level 1 Level 3 Level 2 Level 4
UM UM U M UM UM U M UM UM UM UM UM UM UM UM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3
UMUMUMUMUMUM UMUMUMUMUM U MUMUM
PGA5 PGC TFF1 TFF2 MSLN KRT6AARRDC4CDH1 DUPS6 MLH1 PPARG
TRAP-
PC2L CDKN2ARUNX3410 S.-J. Hong, J.-H. Oh, Y.-C. Jung, et al.
Fig. 3. The methylation status of the methylation-variable sites in the normal mucosa of normal stomachs (A) and 10 bone marrow stromal
cells (B). 
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Fig. 4. Methylation patterns of ulcer-healing (TFF1, TFF2, and CDH1) genes in the normal gastric mucosa analyzed according to the age
groups (A) and H. pylori infection (B). 
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stages 2, 3, and 4 cancers, 46 normal tissues were obtained
from 29 cancer patients due to large-sized cancers. The nor-
mal mucosa of ulcer patients showed significant increases in
the undermethylated PGC (20%, P=0.005), TFF2 (63%,
P=0.001), MLH1 (13%, P=0.003), and PPARG (57%, P<
0.001) genes. The overmethylated CDKN2A (43%, P<0.001)
and RUNX3 (31%, P=0.003) genes were significantly com-
mon in the normal mucosa of non-invasive cancer patients.
Percentages are indicated in parentheses. The frequencies of the over- and under-methylated genes were compared between normal stomach sam-
ples and either ulcer, non-invasive cancer, or invasive cancer patients using a Fisher’s exact test. 
*P values less than 0.01. 
U, undermethylation; I ,intermediate-methylation; O, overmethylation.
Normal stomach (n=140)
UIO
Gene
Ulcer (n=46)
UIO
Non-invasive cancer (n=42)
UIO
Invasive cancer (n=94)
UIO
PGA5 22 (16) 110 (78) 8 (6) 9 (20) 34 (73) 3 (7) 6 (14) 32 (76) 4 (10) 18 (19) 64 (68) 12 (13)
PGC 7 (5) 104 (74) 29 (21) 9 (20)* 28 (60) 9 (20) 6 (14) 26 (62) 10 (24) 15 (16)* 48 (51) 31 (33)
TFF1 31 (22) 56 (40) 53 (38) 16 (35) 22 (48) 8 (17) 13 (31) 17 (40) 12 (29) 34 (36) 37 (39) 23 (25)
TFF2 49 (35) 88 (63) 3 (2) 29 (63)* 15 (33) 2 (4) 14 (33) 26 (62) 2 (5) 22 (23) 61 (65) 11 (12)*
MSLN 4 (3) 131 (93) 5 (4) 2 (4) 41 (89) 3 (7) 3 (7) 39 (93) 0 (0) 2 (2) 83 (88) 9 (10)
KRT6A 8 (6) 121 (86) 11 (8) 3 (7) 37 (80) 6 (13) 2 (5) 38 (90) 2 (5) 5 (5) 62 (66) 27 (29)*
ARRDC4 83 (59) 52 (37) 5 (4) 29 (63) 10 (22) 7 (15) 25 (60) 11 (26) 6 (14) 68 (73) 19 (20) 7 (7)
CDH1 49 (35) 46 (33) 45 (32) 13 (28) 21 (46) 12 (26) 18 (43) 13 (31) 11 (26) 51 (54)* 28 (30) 15 (16)
DUSP6 13 (9) 93 (67) 34 (24) 8 (17) 31 (68) 7 (15) 9 (21) 28 (67) 5 (12) 32 (34)* 52 (55) 10 (11)
MLH1 2 (1) 131 (94) 7 (5) 6 (13)*  40 (87) 0 (0) 1 (2) 36 (86) 5 (12) 11 (12)* 70 (74) 13 (14)
PPARG 28 (20) 102 (73) 10 (7) 26 (57)* 19 (41) 1 (2) 15 (35) 23 (55) 4 (10) 77 (82)* 16 (17) 1 (1)
TRAPPC2L 26 (19) 107 (76) 7 (5) 8 (17) 33 (72) 5 (11) 11 (26) 28 (67) 3 (7) 20 (21) 69 (74) 5 (5)
CDKN2A 34 (24) 93 (67) 13 (9) 5 (11) 33 (72) 8 (17) 4 (10) 20 (48) 18 (42)* 14 (15) 57 (61) 23 (24)*
RUNX3 38 (27) 87 (62) 15 (11) 16 (35) 22 (48) 8 (17) 9 (21) 20 (48) 13 (31)* 37 (39) 42 (45) 15 (16)
Table 3. Methylation-variation profiles of 14 selected genes examined in noncancerous gastric mucosa of cancer and noncancer tis-
sue samples 
Non-invasive cancer (n=42)
No. of cases (%) OR (95% CI)
Old age ≥55 yr
No. of cases (%) OR (95% CI)
Normal control vs. ulcer  140 vs. 46 84 vs. 30
TFF2 inter- or overmethylation 91 (65) vs. 17 (37) 0.3 (0.2-0.6) 51 (61) vs. 7 (23) 0.2 (0.1-0.5) 
PPARG undermethylation 28 (20) vs. 26 (57) 5.2 (2.5-10.6) 15 (18) vs. 17 (57) 6.0 (2.4-15.0)
TFF2-PPARG combined pattern* 14 (10) vs. 8 (17) 1.9 (0.7-4.9) 4 (5) vs. 2 (7) 1.4 (0.3-8.2)
Normal control vs. non-invasive cancer  140 vs. 42 84 vs. 36
TFF2 inter- or overmethylation 91 (65) vs. 28 (67) 1.1 (0.5-2.2) 51 (61) vs. 25 (69) 1.5 (0.6-3.4)
PPARG undermethylation 28 (20) vs. 15 (36) 2.2 (1.0-4.7) 15 (18) vs. 13 (36) 2.6 (1.1-6.3)
TFF2-PPARG combined pattern* 14 (10) vs. 9 (21) 2.5 (0.9-6.1) 4 (5) vs. 8 (22) 5.7 (1.6-20.5)
Normal control vs. stage-1 gastric cancer 140 vs. 48 84 vs. 35
TFF2 inter- or overmethylation 91 (65) vs. 41 (85) 3.2 (1.3-7.6) 51 (61) vs. 30 (86) 3.9 (1.4-11.0)
PPARG undermethylation 28 (20) vs. 38 (80) 15.2 (6.8-34.2) 15 (18) vs. 27 (77) 15.5 (5.9-40.8)
TFF2-PPARG combined pattern* 14 (10) vs. 34 (71) 21.9 (9.5-50.2) 4 (5) vs. 24 (69) 43.6 (12.7-149.6)
Ulcer vs. Stage-1 gastric cancer 46 vs. 48 30 vs. 35
TFF2 inter- or overmethylation 17 (37) vs. 41 (85) 10.0 (3.7-27.2) 7 (23) vs. 30 (86) 19.7 (5.5-70.2)
PPARG undermethylation 26 (57) vs. 38 (80) 2.9 (1.2-7.2) 17 (57) vs. 27 (77) 2.6 (0.9-7.5)
TFF2-PPARG combined pattern* 8 (17) vs. 34 (71) 11.5 (4.3-30.9) 2 (7) vs. 24 (69) 30.5 (6.2-151.6)
Non-invasive vs. Stage-1 gastric cancer 42 vs. 48 36 vs. 35
TFF2 inter- or overmethylation 28 (67) vs. 41 (85) 2.9 (1.0-8.2) 25 (69) vs. 30 (86) 2.6 (0.8-8.6)
PPARG undermethylation 15 (36) vs. 38 (80) 6.8 (2.7-17.5) 13 (36) vs. 27 (77) 6.0 (2.1-16.9)
TFF2-PPARG combined pattern* 9 (21) vs. 34 (71) 8.9 (3.4-23.4) 8 (22) vs. 24 (69) 7.6 (2.6-22.1)
Table 4. Risk estimates for methylation patterns of the TFF2 and PPARG genes analyzed using biopsy samples obtained from the nor-
mal gastric mucosa of ulcer, non-invasive cancer, and stage-1 gastric cancer
*The coexistence of the intermediate- or over-methylated TFF2 and undermethylated PPARG genes.
OR, odds ratio; CI, 95% confidence interval.412 S.-J. Hong, J.-H. Oh, Y.-C. Jung, et al.
The normal mucosa of cancer patients showed significant in-
creases in the overmethylated TFF2 (12%, P=0.004), KRT6A
(29%, P<0.001), and CDKN2A (24%, P=0.003) genes as
well as in the undermethylated PGC (16%, P=0.006), CDH1
(54%, P=0.005), DUSP6 (34%, P<0.001), MLH1 (12%,
P=0.001), and PPARG (82%, P<0.001) genes.
Forty-eight normal tissues from stage-1 cancers and 46 nor-
mal tissues from advanced cancers were separately evaluated
(Fig. 5A). Advanced cancer patients revealed that the TFF2
(15%, P=0.002), KRT6A (46%, P<0.001), and CDKN2A
(26%, P=0.006) genes were significantly overmethylated in
the normal mucosa, and that most of the other genes were
undermethylated (P<0.01). In stage-1 cancer patients, only
the PPARG gene was significantly undermethylated in nor-
mal gastric mucosa (P<0.001). 
The methylation status of the PGA5,PGC,TFF2,PPARG,
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Fig. 5. Methylation-variations in the nor-
mal mucosa of stage-1 and advanced-
stage gastric cancer patients (A) and
comparison of the 6 selected genes
examined in normal mucosa samples
collected 2 cm and 5 cm distal from
pathologic lesions (B). Asterisk indi-
cates statistically significant.
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CDKN2A, and RUNX3 genes in the normal mucosa collect-
ed 2 cm and 5 cm distal from the three gastric lesions (ulcer,
non-invasive cancer, and stage-1 cancer) were comparatively
analyzed (Fig. 5B). The PGA5,CDKN2A, and RUNX3 genes
tended to be increasingly undermethylated in the 2-cm mu-
cosa of the three gastric lesions. The TFF2 gene was the most
overmethylated or barely undermethylated in the two nor-
mal tissues of stage-1 cancer patients and the most under-
methylated in the two normal tissues of ulcer patients. 
Coordinate methylation patterns in normal gastric mucosa
The CDH1 gene with CpG island and the TFF1 and TFF2
genes without CpG islands in the normal mucosa of normal
controls tended to be methylated concurrently with the methy-
lation status of other CpG-island genes (ARRDC4, PPARG,
and RUNX3) and non-island-CpG genes (PGC and MSLN),
respectively (Fig. 6). In the normal mucosa of stage-1 cancer
patients, only the methylation status of the TFF1 gene was
positively associated with that of the PGC gene and the TFF2
Fig. 6. Concurrent methylation status between the ulcer-healing (CDH1, TFF1, and TFF2) genes and the other genes in the normal gastric
mucosa of healthy individuals and stage-1 gastric cancer patients. Correlation coefficients (R) were calculated by Pearson’s correlation.
Asterisk indicates statistically significant. 
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Percentages are indicated in parentheses. The frequencies of the over- and under-methylated genes were compared between normal stomach sam-
ples presented in Table 3 and either 1-cm normal or intra-lesion of non-invasive and invasive cancer patients using a Fisher’s exact test. 
*P values less than 0.01.
U, undermethylation; I, intermediate-methylation; O, overmethylation; MSP, methylation specific PCR.
Non-invasive cancer
1-cm normal (n=21)
UIO
Gene
UIO
Intra-lesion (n=21)
Invasive cancer
1-cm normal (n=36)
UIO UIO
Intra-lesion (n=53)
PGA5 3 (14) 15 (72) 3 (14) 5 (24) 15 (71) 1 (5) 8 (22) 21 (58) 7 (20) 6 (11) 40 (76) 7 (13)
PGC 6 (29)* 12 (57) 3 (14) 14 (67)* 4 (19) 3 (14) 11 (31)* 18 (50) 7 (19) 17 (32)* 25 (47) 11 (21)
TFF1 18 (86)* 0 (0) 3 (14) 19 (90)* 1 (5) 1 (5)* 24 (67)* 7 (19) 5 (14)* 31 (58)* 13 (25) 9 (17)*
TFF2 7 (33) 13 (62) 1 (5) 10 (48) 10 (48) 1 (4) 12 (33) 21 (59) 3 (8) 21 (40) 24 (45) 8 (15)*
MSLN 0 (0) 15 (71) 6 (29)* 2 (10) 11 (52) 8 (38)* 0 (0) 24 (67) 12 (33)* 4 (8) 28 (52) 21 (40)*
KRT6A 2 (10) 9 (42) 10 (48)* 1 (5) 11 (52) 9 (43)* 2 (6) 16 (44) 18 (50)* 9 (17) 24 (45) 20 (38)*
ARRDC4 11 (53) 7 (33) 3 (14) 12 (57) 7 (33) 2 (10) 27 (75) 6 (17) 3 (8) 47 (88)* 3 (6) 3 (6)
CDH1 15 (71)* 5 (24) 1 (5) 19 (90)* 0 (0) 2 (10) 32 (88)* 2 (6) 2 (6)* 44 (83)* 4 (8) 5 (9)*
DUSP6 10 (48)* 9 (42) 2 (10) 11 (52)* 10 (48) 0 (0) 18 (50)* 17 (47) 1 (3)* 25 (47)* 21 (40) 7 (13)
MLH1 0 (0) 16 (76) 5 (24) 0 (0) 8 (38) 13 (62)* 3 (8) 26 (72) 7 (20) 19 (36)* 24 (45) 10 (19)*
PPARG 14 (67)* 5 (23) 2 (10) 17 (80)* 2 (10) 2 (10) 31 (86)* 4 (11) 1 (3) 38 (72)* 10 (19) 5 (9)
TRAPPC2L 3 (14) 11 (52) 7 (34)* 2 (10) 12 (57) 7 (33)* 2 (6) 21 (58) 13 (36)* 9 (17) 35 (66) 9 (17)
CDKN2A 5 (24) 9 (43) 7 (33)* 7 (33) 2 (10) 12 (57)* 13 (36) 10 (28) 13 (36)* 29 (55)* 14 (26) 10 (19)
RUNX3 12 (57)* 6 (29) 3 (14) 3 (14) 6 (29) 12 (57)* 13 (36) 18 (50) 5 (14) 7 (13) 19 (36) 27 (51)*
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gene was weakly associated with the PGC gene. In addition,
in stage-1 cancer patients, the methylation of the TFF1 and
TFF2 genes tended to be positively and negatively associat-
ed with that of the PPARG gene, respectively, although the
relationships did not reach a statistical significance. 
Odds ratios were estimated for the methylation patterns of
the TFF2 and PPARG genes in the normal gastric mucosa
of ulcer, non-invasive cancer, and stage-1 cancer patients (Table
4). The intermediate- or over-methylated TFF2 gene was more
common in stage-1 cancer patients than in ulcer patients (85%
vs. 37%, respectively; OR, 10.0; 95% CI, 3.7-27.2). The un-
dermethylated PPARG gene was more common in cancer
patients than in non-invasive cancer patients (80% vs. 36%,
respectively; OR, 6.8; 95% CI, 2.7-17.5). A biopsy case show-
ing the intermediate- or over-methylated TFF2 and under-
methylated PPARG genes was defined as a discordant methy-
lation pattern. When control individuals and stage-1 cancer
patients were compared, the discordant TFF2-PPARG pat-
tern was more common in stage-1 cancer patients (71% vs.
10%, respectively; OR, 21.9; 95% CI, 9.5-50.2) and the asso-
ciation with cancer patients was stronger in the older-age group
(≥55 yr; 69% vs. 5%, respectively; OR, 43.6; 95% CI, 12.7-
149.6). The discordant TFF2-PPARG pattern was more com-
mon in cancer patients than in ulcer patients (17%; OR, 11.5;
95% CI, 4.3-30.9) or non-invasive cancer patients (21%; OR,
8.9; 95% CI, 3.4-23.4). 
Methylation-variations in non-invasive and invasive 
cancerous lesions
Of the six stomach-related or ulcer-healing genes examin-
ed in this study, only the TFF2 gene was significantly over-
methylated in the cancerous lesions (15%, P=0.002) (Table
5). The PGC, TFF1, CDH1, DUSP6, and PPARG genes
were largely undermethylated in both the non-invasive and
invasive cancerous lesions (P<0.01). The MSLN and KRT6A
genes were frequently overmethylated in both the non-inva-
sive and invasive cancerous lesions (P<0.01). In the normal
mucosa collected from within 1-cm of the non-invasive and
invasive cancer margins, the methylation status of the genes
showed a trend similar to that observed in the non-invasive
and invasive cancerous lesions. However, the RUNX3 gene
was significantly undermethylated in the 1-cm mucosa of
non-invasive cancer patients, despite the common occurrence
of overmethylation in non-invasive cancerous lesions and 2-
and 5-cm normal mucosa.
DISCUSSION
In the normal gastric mucosa obtained from healthy indi-
viduals, the methylation-variable sites of ulcer-healing genes
were concurrently methylated with other genes depending
on the presence or absence of CpG islands (Fig. 6). These con-
current methylation patterns agree the results of other stud-
ies reporting that the epigenetic structure of tissue-specific
and housekeeping genes are co-regulated to preserve a tissue
environment (8). Both the TFF2 and PPARG genes were
primarily undermethylated in normal mucosa of ulcer pati-
ents (Table 3). It is well known that the PPARG gene is in-
volved in the gastric mucosal defense mechanism through
up-regulation of TFF1 and TFF2 expression (9, 11). The con-
current methylation of the TFF2 and PPARG genes is com-
patible with wound healing and could mediate the mucosal
defense system adequately in response to mucosal injuries.
Therefore, the results of this study imply that the coordinate
methylation of ulcer-healing genes is normally programmed
in a gastric tissue environment to enable efficient recovery
from mucosal damage.
The TFF1, CDH1, DUSP6, PPARG, and RUNX3 genes,
which all play a role in stimulating mucosal growth or reg-
ulating the ulcer-healing process (9-11, 17, 20), tended to be
extensively undermethylated in the normal mucosa of advanc-
ed-stage cancer patients (Fig. 5A). Meanwhile, the KRT6A
and MSLN non-gastric genes without CpG islands in non-
invasive and invasive cancer lesions as well as their 1-cm mu-
cosa, which have a high cell growth rate, were found to be
overmethylated. With respect to the methylation kinetics,
previous studies evaluating the induction of cell differentia-
tion have suggested that rapid cell division allows the under-
methylation of the key tissue-specific genes to ensure cell pro-
liferation and differentiation in a given tissue (23, 27). Con-
sequently, the extensive undermethylation of the house-keep-
ing and stomach-related genes may be a manifestation of the
normal cell-intrinsic program that accelerates the mucosal
growth in response to mucosal injuries. 
The methylation profiles of the TFF1, TFF2, and CDH1
genes in the stomach of the younger-aged individuals (Fig.
4A) were different from those in the bone marrow samples
(Fig. 3B). However, the three ulcer-healing genes in the stom-
ach of older-aged individuals showed marrow-like methyla-
tion patterns, such as increases in overmethylated TFF1, un-
dermethylated TFF2, and undermethylated CDH1 genes.
Moreover, a previous study showed that H. pylori-infected gas-
tric mucosa was associated with Polycomb proteins that reg-
ulate both DNA methylation and histone modification in
pluripotent marrow cells (28). Therefore, it is likely that the
gastric mucosa of older healthy individuals remodeled the epi-
genetic structure under the influence of H. pylori infection that
promoted the recruitment of marrow-derived stem cells (4).
Because highly expressed TFF1 and TFF2 genes, which
play a master role in mucosal repair (9), can self-organize a
chromatin compartment for coordinate gene expression (8),
it is likely that the methylation patterns of the two master
genes influence their gene-specific chromatin structures as
well as other gastric genes in the gastric mucosa. In this study,
the TFF1 gene was tended to be methylated concurrent with
the genes with and without CpG islands in normal stomachDNA Methylation in Normal Mucosa of Gastric Cancer 415
samples. The methylation status of the TFF2 gene was asso-
ciated with that of the PGC and MSLN genes without CpG
islands. In a recent study, the TFF1 gene was densely methy-
lated in extraneous tissues and the TFF2, PGC, and MSLN
genes were weakly methylated irrespective of their expression
patterns (26). When applying the self-organization model
to the stomach, the relative undermethylation of the TFF1
gene with dense-methylation site nucleates a transcription
center and recruits a group of genes for the coordinated gene
expression, and the TFF2, PGC, and MSLN genes with weak-
methylation site subsequently participate in gene regulation.
The weak methylation sites are likely to be variably methy-
lated and selected to coordinate gastric-specific methylation
patterns and gene expression in the gastric tissue environment.
The weak-methylation site of the TFF2 gene tended to
be weakly or negatively associated with that of the PGC and
PPARG genes in normal mucosa of stage-1 cancer patients
(Fig. 6). The TFF2 gene was more methylated in stage-1 can-
cer patients than in ulcer patients, although the PPARG gene
was significantly undermethylated in both cancer and ulcer
patients (Table 4). This TFF2 methylation pattern indicates
incomplete or aberrant coordination of highly expressed gas-
tric gene, which may allow for the reactivation of marrow tran-
scription patterns and cause the pluripotent stem cells to be
vulnerable to neoplastic transformation. In this regard, the
presence of discordant TFF2 methylation in the normal mu-
cosa beyond the pathologic lesions is an indication of wide
distribution of the cancer-prone progenitor cells (also known
as field cancerization) (29).
A recent study suggests that the transcription-ready state
of pluripotent marrow cells suppressing non-island-CpG genes
is provided with the low-level methylation of CpG-island
margins, while the gastric-specific genes lacking CpG islands
in the stomach tissue are up-regulated with a concert effect
of increasingly methylated CpG-islands (26). Additionally,
gastric-gene expression was found to decrease in cancer tis-
sues that reduced CpG-island methylation (Fig. 1, Table 5).
Previous studies also have shown variable hypermethylation
of CpG islands in H. pylori-infected mucosa of both non-can-
cer individuals and cancer patients, but a correlation between
CpG-island methylation and gene silencing was obscure (30).
Therefore, it is possible that the increased methylation of mul-
tiple CpG islands including the CDH1 gene up-regulates the
gastric genes lacking CpG islands and leads to the adaptive
differentiation of marrow stem cells. 
Pluripotent marrow cells are known to express Polycomb
proteins to promote DNA methylation based on the epige-
netic memory module that drives multilineage differentiation
(28). Therefore, the hypermethylated CpG islands appears to
be a vestige of DNA methylation associated with the adap-
tive differentiation of marrow stem cells in extraneous tissues.
The three cancer-associated genes with CpG islands (RUNX3,
MLH1, and CDKN2A) were commonly overmethylated in
the gastric cancer lesions (Table 5), but not in normal mucosa
of stage-1 cancer patients. This is consistent with previous
studies reporting that the hypermethylated genes common
in cancer tissues are not common in the nearby normal gas-
tric mucosa (30). The CpG-island methylation associated with
the adaptation of marrow stem cells appears to involve the
cancer-associated genes, which are not frequent to be detect-
ed in cancer-risk mucosa.
The methylation status of the RUNX3 gene that has a long
CpG island varies greatly in the normal gastric mucosa depen-
dent on the distance from the pathologic lesions. For exam-
ple, the overmethylated RUNX3 gene was common in the
5-cm mucosa of non-invasive cancer and stage-1 cancer pati-
ents; however the undermethylated RUNX3 gene was com-
mon in the 1-cm mucosa of non-invasive cancer patients as
well as in the normal mucosa of advanced-stage cancer pati-
ents (Fig. 5B, Table 5). This indicates that the tissue damage
effect of gastric cancers could induce a subsequent undermethy-
lation in overmethylated RUNX3 genes that preexisted in
gastric cancer patients, which resulted in there being no sig-
nificant difference in RUNX3 methylation between healthy
individuals and stage-1 gastric cancer patients. In the normal
gastric mucosa of non-invasive cancer patients, the CDKN2A
and RUNX3 CpG-islands were the most overmethylated, with
no single gene being significantly undermethylated (Table 3).
These findings suggest that the variable methylation of CpG
islands requires interpretation in terms of gene coordination
associated with mucosal injury and H. pylori infection.
Individuals with gastric atrophy and mucosal injuries devel-
op various clinical courses that range from a benign ulcer to
non-invasive cancer and cancer or both during their lifetime
(3). The methylation patterns of the ulcer-healing genes exam-
ined in this study suggest that epigenetic adaptation occurs
in the gastric tissue environment and facilitates mucosal repair
and regeneration during the individual’s lifetime. In addition,
genomic DNA obtained from a small biopsy tissue of the nor-
mal gastric mucosa showed a discordant methylation pattern
of the TFF2 and PPARG genes, which was strongly associ-
ated with the normal mucosa of stage-1 gastric cancer patients.
Therefore, these methylation-variable sites could serve as a
sensitive marker for predicting cancer-prone gastric mucosa
prior to the development of gastric cancer.
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